Ligands for phosphatase binding assay
CA 2269637 A1 · Owner: Desmarais, Sylvie · Inventors: Zamboni, Robert; Friesen, Richard; Desmarais, Sylvie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are new ligands for use in a binding assay for proteases and phosphatases, which contain cysteine in their binding sites or as a necessary structural component for enzymatic binding. The sulfhydryl group of cysteine is the nucleophilic group in the enzyme's mechanistic proteolytic and hydrolytic properties. The assay can be used to determine the ability of new unknown ligands and mixtures of compounds to competitively bind with the enzyme versus a known binding agent for the enzyme e.g. a known enzyme , inhibitor. By the use of a mutant form of the natural or native wild-type enzyme, in which serine, or another amino acid e.g. alanine, replaces , cysteine, the problem of …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 3, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 3, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 3, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.